...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Announces Conversion of US$12 Million Debenture Strengthening Balance Sheet

$1 Billion CAD?  LOL

I could swear you were the one who posted this research link: https://seekingalpha.com/article/4314267-real-value-of-breakthrough-therapy-designation

which identifies $8.3 Billlion USD as an average market cap for companies that just received FDA BTD (that average includes lots of orphan, thin markets).  We have a safe drug for major conditions and we are currently valued at one-fortieth to one-fiftieth of that basic average market cap.  

Share
New Message
Please login to post a reply